Evaluation of bleeding in patients receiving direct oral anticoagulants

Evaluation of bleeding in patients receiving direct oral anticoagulants

Erika L Hellenbart,1 Kathleen D Faulkenberg,2 Shannon W Finks3 1University of Illinois at Chicago College of Pharmacy, Chicago, IL, 2Cleveland Clinic, Cleveland, OH, 3University of Tennessee College of Pharmacy, Memphis, TN, USA Abstract: Direct oral anticoagulants (DOACs) are recognized by evidence...

Full description

Bibliographic Details
Main Authors: Hellenbart EL, Faulkenberg KD, Finks SW
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:Vascular Health and Risk Management
Subjects:
Bleeding
Direct Oral Anticoagulants
Dabigatran
Rivaroxaban
Apixaban
Edoxaban
Online Access:https://www.dovepress.com/evaluation-of-bleeding-in-patients-receiving-direct-oral-anticoagulant-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/evaluation-of-bleeding-in-patients-receiving-direct-oral-anticoagulant-peer-reviewed-article-VHRM

Similar Items